ADVERTISEMENT
early-stage safety testing but have not yet received full approval from the U.S. Food and Drug Administration. Supporters of the policy argue it gives patients additional options during life-threatening illnesses, while critics warn that unproven treatments can create unrealistic expectations. Medical experts emphasized that while experimental therapies continue reading …
ADVERTISEMENT